Dr Dharmintra Pasupathy MB ChB MSc PhD MRCOG Consultant Obstetrician
Dharmintra Pasupathy is a consultant obstetrician and sub-specialist in maternal and fetal medicine at Guy’s and St Thomas’ NHS Foundation Trust. He completed his post-graduate training in Bristol and Cambridge and his fellowship in maternal and fetal medicine at Guy’s and St Thomas’ Hospital. He is a member of the Royal College of Obstetricians and Gynaecologists. Dr Pasupathy is also a senior lecturer in maternal and fetal medicine and perinatal epidemiology at King’s College London. He was awarded his PhD from the University of Cambridge and his specialist interest is in the prevention of adverse outcomes of labour and delivery.
Dr Pasupathy’s current NHS clinical practice is in fetal medicine and in the high risk antenatal and diabetes in pregnancy service. He offers private maternity care to both women with low and high risk pregnancies, with the expertise to provide care in cases when complications occasionally arise. Despite the background of the pregnancy, he is focused on ensuring that all pregnancies remain a positive experience for the parents.
Dr Dharmintra Pasupathy’s private maternity care is structured as follows:
· Comprehensive maternity care package – This includes antenatal care, prenatal screening, care during labour and post-natal care. He personally performs all ultrasounds scans in pregnancy and is accessible throughout pregnancy and following delivery for his patients.
· Care for labour and delivery – He provides care to women who decide on private maternity care only late in pregnancy for labour and delivery.
· Ultrasounds scans in pregnancy – He performs scans throughout pregnancy which include early viability scans, nuchal translucency and dating scans, ultrasound screening for fetal anomalies and growth surveillance, 3D / 4D and fetal sexing scans.
· Prenatal screening – These are comprehensive screening tests for common chromosomal and fetal abnormalities, such as Down’s Syndrome and includes an early scan performed at 11-14 weeks.
· Pre-natal diagnostic tests – He offers a definitive diagnostic test to women at high risk following prenatal screening, or to women who opt for a definitive test independent of the screening test results. These include chorionic villous sampling (CVS) and amniocentesis.